Fecal matter can save lives: the U.S. created the Bank of the “healthy” feces

If weakened immunity in the intestine may begin uncontrolled multiplication of bacteria clostridia, which are relatively insensitive to antibiotics. Salvation brings the introduction into the intestine the stool of healthy people, naturally, that the United States created the first Bank of donor feces.

Every year even in a country like the US with their advanced medicine bowel disease caused by the bacteria Clostridium (mainly of 2 types – Clostridium perfringens and Clostridium difficile) have taken the lives of at least 14 000 people.

Victims of clostridia, as a rule, are people with a weakened immune system: premature infants, the elderly, people with chronic diseases (e.g. HIV-infected). In many cases, the reason for the proliferation of clostridia becomes the use of antibiotics that kill competing gut flora.

The cause of death of patients becomes a pseudomembranous colitis associated with antibiotic use.

A few years ago, American doctors has proposed a new, very unusual, but extremely effective method of treatment of infections caused by Clostridium.

Method is called “fecal transplantation,” as it involves the introduction into the intestine of the patient via enema or colonoscope, a small amount of stool from a healthy person with normal microflora.

Within a few days the microflora begins to inhibit the proliferation of clostridia and the person recovers.

However, the production and preparation of “fecal transplants” for obvious reasons, is a rather unpleasant task.

To simplify the treatment of patients with Clostridium with transplanting someone else’s feces are scientists from mit (Massachusetts Institute of Technology). They created a company OpenBiome, which is nothing but a Bank of cal.

Fecal material obtained from donors tested, processed and placed in a tightly closed, unbreakable vessels, which are stored in the refrigerator.

Upon receipt of an application container, containing “fecal transplant” is sent immediately to the customer.

The company supplies the “donor material” only medical institutions and never considers applications from individuals.

Leave a Reply